These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 8632409)
1. Comparative molecular field analysis-based prediction of drug affinities at recombinant D1A dopamine receptors. Brusniak MY; Pearlman RS; Neve KA; Wilcox RE J Med Chem; 1996 Feb; 39(4):850-9. PubMed ID: 8632409 [TBL] [Abstract][Full Text] [Related]
2. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors. Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114 [TBL] [Abstract][Full Text] [Related]
3. CoMFA-based prediction of agonist affinities at recombinant wild type versus serine to alanine point mutated D2 dopamine receptors. Wilcox RE; Huang WH; Brusniak MY; Wilcox DM; Pearlman RS; Teeter MM; DuRand CJ; Wiens BL; Neve KA J Med Chem; 2000 Aug; 43(16):3005-19. PubMed ID: 10956209 [TBL] [Abstract][Full Text] [Related]
5. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine. Negash K; Nichols DE; Watts VJ; Mailman RB J Med Chem; 1997 Jul; 40(14):2140-7. PubMed ID: 9216832 [TBL] [Abstract][Full Text] [Related]
6. Improved models for pharmacological null experiments: calculation of drug efficacy at recombinant D1A dopamine receptors stably expressed in clonal cell lines. Mak CK; Avalos M; Randall PK; Kwan SW; Abell CW; Neumeyer JL; Whisennand R; Wilcox RE Neuropharmacology; 1996 May; 35(5):549-70. PubMed ID: 8887963 [TBL] [Abstract][Full Text] [Related]
7. Cloning and characterization of the opossum kidney cell D1 dopamine receptor: expression of identical D1A and D1B dopamine receptor mRNAs in opossum kidney and brain. Nash SR; Godinot N; Caron MG Mol Pharmacol; 1993 Nov; 44(5):918-25. PubMed ID: 8246914 [TBL] [Abstract][Full Text] [Related]
8. Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods. Hoffman B; Cho SJ; Zheng W; Wyrick S; Nichols DE; Mailman RB; Tropsha A J Med Chem; 1999 Aug; 42(17):3217-26. PubMed ID: 10464009 [TBL] [Abstract][Full Text] [Related]
10. 8,9-dihydroxy-1,2,3,11b-tetrahydrochromeno[4,3,2,-de]isoquinoline (dinoxyline), a high affinity and potent agonist at all dopamine receptor isoforms. Grubbs RA; Lewis MM; Owens-Vance C; Gay EA; Jassen AK; Mailman RB; Nichols DE Bioorg Med Chem; 2004 Mar; 12(6):1403-12. PubMed ID: 15018913 [TBL] [Abstract][Full Text] [Related]
11. Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via comparative molecular field analysis. Huang Q; Liu R; Zhang P; He X; McKernan R; Gan T; Bennett DW; Cook JM J Med Chem; 1998 Oct; 41(21):4130-42. PubMed ID: 9767648 [TBL] [Abstract][Full Text] [Related]
12. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats. Shuto T; Seeman P; Kuroiwa M; Nishi A Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579 [TBL] [Abstract][Full Text] [Related]
17. Application of validated QSAR models of D1 dopaminergic antagonists for database mining. Oloff S; Mailman RB; Tropsha A J Med Chem; 2005 Nov; 48(23):7322-32. PubMed ID: 16279792 [TBL] [Abstract][Full Text] [Related]
18. Studies of molecular pharmacophore/receptor models for GABAA/benzodiazepine receptor subtypes: binding affinities of substituted beta-carbolines at recombinant alpha x beta 3 gamma 2 subtypes and quantitative structure-activity relationship studies via a comparative molecular field analysis. Huang Q; Cox ED; Gan T; Ma C; Bennett DW; McKernan RM; Cook JM Drug Des Discov; 1999 Jul; 16(1):55-76. PubMed ID: 10466057 [TBL] [Abstract][Full Text] [Related]
19. Induction of the estrogen specific mitogenic response of MCF-7 cells by selected analogues of estradiol-17 beta: a 3D QSAR study. Wiese TE; Polin LA; Palomino E; Brooks SC J Med Chem; 1997 Oct; 40(22):3659-69. PubMed ID: 9357533 [TBL] [Abstract][Full Text] [Related]
20. Dibenzazecine compounds with a novel dopamine/5HT2A receptor profile and 3D-QSAR analysis. Hamacher A; Weigt M; Wiese M; Hoefgen B; Lehmann J; Kassack MU BMC Pharmacol; 2006 Sep; 6():11. PubMed ID: 16978403 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]